UBS Maintains a 'Buy' on Abbott Labs (ABT); Raising Price Target After Solid Quarter

July 19, 2012 1:19 PM EDT Send to a Friend
UBS maintains a 'Buy' on Abbott Labs (NYSE: ABT) price target of $72.00 (from $68.00).

Analyst, Rajeev Jashnani, said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login